Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma

被引：0
|
作者：
V. E. Goldberg
T. Yu. Polyakova
N. O. Popova
V. V. Vysotskaya
E. I. Simolina
Yu. V. Belevich
T. P. Tuzikova
A. V. Goldberg
V. V. Zhdanov
L. A. Miroshnichenko
E. V. Udut
E. V. Simanina
A. M. Dygai
G. N. Zyuz’kov
机构：
[1] E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine,
[2] Research Institute of Oncology,undefined
[3] Tomsk National Research Medical Center,undefined
[4] National Research Tomsk State University,undefined
来源：
Bulletin of Experimental Biology and Medicine | 2017年 / 163卷
关键词：
non-small-cell lung carcinoma; granulocytopoiesis; erythropoiesis; docetaxel; cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The toxic effects of combined cisplatin/docetaxel therapy cycles on erythroid and granulocytic hematopoietic lineages as well as their intercycle recovery were examined in patients with stage III-IV non-small-cell lung carcinoma. Responsiveness of the blood system to this therapy remained at a high level. Combined therapy pronouncedly activated the key elements of the erythroid and granulocytic hematopoietic lineages leading to accumulation of immature and mature myelokaryocytes in the bone marrow, enlargement of the medullary pool of mature neutrophils, and increase in the count of medullary erythroid and granulocytic precursor cells under conditions of their accelerated maturation.
引用
收藏
页码：469 / 474
页数：5
相关论文
共 50 条
  • [21] Relevance of EGFR gene mutation with pathological features and prognosis in patients with non-small-cell lung carcinoma
    Cheng-De Wang
    Xin-Rong Wang
    Chao-Yang Wang
    Yi-Jun Tang
    Ming-Wen Hao
    Asian Pacific Journal of Tropical Medicine, 2015, (03) : 249 - 252
  • [22] Palmar fasciitis and polyarthritis syndrome associated with non-small-cell lung carcinoma
    Claire Sheehy
    John G. Ryan
    Michael Kelly
    Maurice Barry
    Clinical Rheumatology, 2007, 26 : 1951 - 1953
  • [23] Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma
    Iida, S.
    Kakinuma, H.
    Miki, Y.
    Abe, K.
    Sakurai, M.
    Suzuki, S.
    Niikawa, H.
    Akahira, J.
    Suzuki, T.
    Sasano, H.
    BRITISH JOURNAL OF CANCER, 2013, 108 (07) : 1415 - 1424
  • [24] Length of Diagnostic Delay in Patients with Non-small-cell Lung Cancer
    Valdes, Solangel
    Garcia, Eberto
    Perez, Hayvin
    Hernandez, Marisela
    MEDICC REVIEW, 2010, 12 (01) : 29 - 32
  • [25] Palmar fasciitis and polyarthritis syndrome associated with non-small-cell lung carcinoma
    Sheehy, Claire
    Ryan, John G.
    Kelly, Michael
    Barry, Maurice
    CLINICAL RHEUMATOLOGY, 2007, 26 (11) : 1951 - 1953
  • [26] Durvalumab in non-small-cell lung cancer patients: current developments
    Mezquita, Laura
    Planchard, David
    FUTURE ONCOLOGY, 2018, 14 (03) : 205 - 222
  • [27] Avelumab in non-small-cell lung cancer
    Rosell, Rafael
    Karachaliou, Niki
    LANCET ONCOLOGY, 2018, 19 (11) : 1423 - 1424
  • [28] Nintedanib for the treatment of patients with advanced non-small-cell lung cancer
    Reck, Martin
    Heigener, David
    Reinmuth, Niels
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (05) : 579 - 590
  • [29] Identification of Biomarkers for Non-small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor
    Kubo, Sousuke
    Kobayashi, Nobuaki
    Somekawa, Kohei
    Hirata, Momo
    Kamimaki, Chisato
    Aiko, Hiroko
    Katakura, Seigo
    Teranishi, Shuhei
    Watanabe, Keisuke
    Hara, Yu
    Yamamoto, Masaki
    Kudo, Makoto
    Kaneko, Takeshi
    ANTICANCER RESEARCH, 2020, 40 (07) : 3889 - 3896
  • [30] Long term survival in non-small-cell lung carcinoma with synchronous brain metastasis
    Aggarwal, Rupali
    Dimri, Kislay
    Pandey, Awadhesh Kumar
    THORACIC CANCER, 2010, 1 (04) : 172 - 174
12345